Hazardous Infusion Drug Administration in the Home Setting

Recorded On: 07/25/2018

Hazardous drug (HD) agents traditionally have been administered in controlled, health care settings. However, the introduction of intravenous (IV) HDs for home administration has become an area of growing concern for home care agencies and home infusion nurses. The United States Pharmacopeia (USP) has regulated the admixture and handling of HDs for controlled settings, and its role is now expanding to include all areas in the trajectory of care. Home infusion is one aspect of care that will require nursing education, policies and procedures, and appropriate personal protective equipment. Successful implementation of USP <800> regulations will require home health infusion teams to develop a hazardous drug administration and exposure management plan to protect infusion nurses, patients and families, and the environment from toxic residue exposure. 

Learning Outcomes: At the conclusion of this session, learners will be able to: 
• Discuss the impact USP <800> will have on home infusion nurses.
• Recognize the risks to nurses, patients and families, and the environment associated with intravenous (IV) drug residue exposure.
• Identify necessary safety precautions when administering IV chemotherapy and other HDs in the home.
• Review specific patient and family education that may prevent and/or reduce the risk of HD exposure in the home.

Cynthia Huff, MSN, RN, CRNI®, OCN®, CNL

Home Infusion Coordinator

Cynthia Huff, MSN, RN, CRNI®, OCN®, CNL, is a home infusion coordinator at Sutter Infusion & Pharmacy Services in Sacramento, California. Her experience as an infusion and oncology nurse spans more than 20 years. Ms. Huff’s current nursing focus is to protect health care workers, patients and families, and the environment from exposure to hazardous drug residue as the administration of oral and intravenous chemotherapy increasingly takes place in patients’ homes. Ms. Huff earned a master’s degree in nursing from the University of San Francisco (USF) and recently obtained certification as a clinical nurse leader (CNL). She is currently enrolled in USF’s doctor of nursing practice degree program, with a focus on population health leadership. Her goal is to teach nursing practice.  

Rosangel Klein, MS, RN, CNS, OCN®

Oncology Clinical Nurse Specialist

Rosangel Klein, MS, RN, CNS, OCN®, is the oncology clinical nurse specialist at Sutter Roseville Medical Center. She has held a number of leadership positions at Sutter Health. Most recently, she was Sutter Health Valley Area’s interim oncology service line executive and oncology service line clinical director. As service line clinical director, she was responsible for clinical integration across the continuum of care. Before this role, she served as the regional infusion center manager for Sutter Roseville Medical Center, where she worked for 4 years and was instrumental in the growth of the infusion center. She assisted in opening a new comprehensive cancer center in 2016. Ms. Klein earned a bachelor’s degree in nursing from the University of San Francisco and completed a master’s degree in oncology nursing at the University of California San Francisco.   


Director for Professional Practice and Nursing Excellence

Surani Kwan, MBA, MSN, NP-BC, FACHE, FAAN, is director for professional practice and nursing excellence for Sutter Health, where she is responsible for advancing professional practice throughout system affiliates, and providing leadership in professional development, clinical education, and training for nursing and advanced practice clinicians. She was previously the executive director of operations for the Sutter Pacific Medical Foundation. Kwan has been a member of the California Association for Nurse Practitioners for nearly 20 years and served as the association’s president for 2 terms. Currently pursuing a doctorate in nursing practice at Samuel Merritt University in Oakland, California, Kwan holds a master’s of science degree in nursing and a master’s degree in business administration. She is also a certified family nurse practitioner and a Fellow of the American Association for Nurse Practitioners and the American College of Healthcare Executives.

CRNI® RUs: This session has been approved for 1 CRNI® recertification unit and meets the non INS Meeting criteria.

Contact Hours: This session has been approved for 1 contact hour

Expiration date for receipt of contact hours: July 25, 2021


Live event: 07/25/2018 at 1:00 PM (EDT) You must register to access.
Webinar Evaluation
Printable Certificate You must register to access.